Patents Examined by Marjan Fardanesh
  • Patent number: 10660553
    Abstract: Method and apparatus for providing reliable blood oxygen (SaO2) and heart rate measurements includes a chemical energy heating source in conjunction with a harness that is adapted to secure the chemical energy heating source and a pulse oximeter probe proximate to a region of the body which is to be warmed prior to measurement. Preferably, the chemical energy heating source is in the form a mixture including a metal powder, which releases heat at a predetermined rate via oxidation of the metal powder when exposed to the atmosphere. The apparatus may be designed to be reusable or disposable and can be used in a transmission or reflectance mode, or both.
    Type: Grant
    Filed: September 7, 2017
    Date of Patent: May 26, 2020
    Assignee: U.S. Department of Veteran Affairs
    Inventor: Catherine P. Abee
  • Patent number: 10646147
    Abstract: A sensor insertion assembly includes: a sensor insertion device comprising a needle member configured to be inserted in a living body together with a biological information sensor and to be pulled out of the living body after leaving a distal end side of the sensor in the living body; and a base plate detachably attached to a first end side of the sensor insertion device, the base plate comprising a clamp portion configured to move so as to clamp a proximal end side of the sensor extending to an outside of the living body after pulling out the needle member and along with an operation of detaching the sensor insertion device from the base plate.
    Type: Grant
    Filed: July 12, 2017
    Date of Patent: May 12, 2020
    Assignee: TERUMO KABUSHIKI KAISHA
    Inventors: Takeshi Tsubouchi, Eiji Arita, Hideyuki Momoki
  • Patent number: 10646146
    Abstract: A non-invasive, optical-based physiological monitoring system is disclosed. One embodiment includes an emitter configured to emit light. A diffuser is configured to receive and spread the emitted light, and to emit the spread light at a tissue measurement site. The system further includes a concentrator configured to receive the spread light after it has been attenuated by or reflected from the tissue measurement site. The concentrator is also configured to collect and concentrate the received light and to emit the concentrated light to a detector. The detector is configured to detect the concentrated light and to transmit a signal representative of the detected light. A processor is configured to receive the transmitted signal and to determine a physiological parameter, such as, for example, arterial oxygen saturation, in the tissue measurement site.
    Type: Grant
    Filed: August 5, 2019
    Date of Patent: May 12, 2020
    Assignee: Masimo Corporation
    Inventor: Ammar Al-Ali
  • Patent number: 10646143
    Abstract: Non-invasive optical detection devices and techniques that use optically discriminative detection of returned probe light from a target by spatially separating the returned probe light from the deep tissue structure and the returned probe light from the skin surface and the shallow tissue structure based on different wave vector components to improve the optical detection sensitivity in detecting the returned probe light from the deep tissue structure with reduced optical interference by the returned probe light form the skin surface and the shallow tissue structure.
    Type: Grant
    Filed: March 8, 2013
    Date of Patent: May 12, 2020
    Assignee: Alethus, Inc.
    Inventor: Feiling Wang
  • Patent number: 10638961
    Abstract: A non-invasive, optical-based physiological monitoring system is disclosed. One embodiment includes an emitter configured to emit light. A diffuser is configured to receive and spread the emitted light, and to emit the spread light at a tissue measurement site. The system further includes a concentrator configured to receive the spread light after it has been attenuated by or reflected from the tissue measurement site. The concentrator is also configured to collect and concentrate the received light and to emit the concentrated light to a detector. The detector is configured to detect the concentrated light and to transmit a signal representative of the detected light. A processor is configured to receive the transmitted signal and to determine a physiological parameter, such as, for example, arterial oxygen saturation, in the tissue measurement site.
    Type: Grant
    Filed: August 5, 2019
    Date of Patent: May 5, 2020
    Assignee: Masimo Corporation
    Inventor: Ammar Al-Ali
  • Patent number: 10632009
    Abstract: An obstructive sleep apnea detection device including an optical engagement surface adapted to engage a user's skin; a light source adapted to emit light from the optical engagement surface; a photodetector adapted to detect light at the optical engagement surface and to generate a detected light signal; a position sensor adapted to determine patient sleeping position; a controller adapted to determine and record in memory blood oxygen saturation values computed from the detected light signal and user position information from the position sensor; and a housing supporting the optical engagement surface, the photodetector, the light source, the position sensor, and the controller.
    Type: Grant
    Filed: November 19, 2018
    Date of Patent: April 28, 2020
    Assignee: HANCOCK MEDICAL, INC.
    Inventors: Thomas G. Goff, Kirby Chiang, Nathaniel L. Bowditch
  • Patent number: 10617337
    Abstract: A substance concentration monitoring method includes inducing a periodic change in a body surface temperature over time using a heating and/or cooling element and yielding a function of temperature that varies with time so as to exhibit a temperature derivative with respect to time that oscillates periodically. Mid-infrared radiation absorbed or emitted from the body is measured while the surface of the body exhibits the oscillating, periodic derivative. The method includes determining a measured value based on the MIR radiation measurements and determining a concentration of a substance in the body based on a correlation with the measured value. A substance concentration monitoring apparatus includes a processor that initiates operations continuously monitoring whether the concentration or the measured value are within a tolerance. The operations further include generating a warning output when the concentration or the measured value is outside the tolerance.
    Type: Grant
    Filed: June 19, 2015
    Date of Patent: April 14, 2020
    Assignee: GlucoVista Inc.
    Inventors: Yonatan Gerlitz, Efraim Landa
  • Patent number: 10617335
    Abstract: A regional oximetry sensor has a sensor head attachable to a patient skin surface so as to transmit optical radiation into the skin and receive that optical radiation after attenuation by blood flow within the skin. The sensor includes windows that press into the skin to maximize optical transmission. A stem extending from the sensor head transmits electrical signals between the sensor head and an attached cable. In a peel resistant configuration, the stem is terminated interior to the sensor head and away from a sensor head edge so as to define feet along either side of the stem distal the stem termination. The stem interior termination transforms a peel load on a sensor head adhesive to less challenging tension and shear loads on the sensor head adhesive.
    Type: Grant
    Filed: February 8, 2018
    Date of Patent: April 14, 2020
    Assignee: Masimo Corporation
    Inventors: Ammar Al-Ali, Kevin Forrest, Yassir Abdul-Hafiz, Walter M. Weber, Pete Mangosing, Sujin Hwang
  • Patent number: 10617360
    Abstract: An apparatus for measuring a bio-signal includes: a light source emitting a predetermined amount of light into a human body; a light receiving unit receiving at least some of the predetermined amount of light; and a cover, which is touchable by the human body, protecting the light source and the light receiving unit. The light source and the cover are arranged such that the light source and the cover are separated by a first gap, the light receiving unit and the cover are arranged such that the light receiving unit and the cover are separated by a second gap, and the first gap is less than the second gap.
    Type: Grant
    Filed: August 29, 2016
    Date of Patent: April 14, 2020
    Assignees: Hyundai Motor Company, LG Innotek Co., LTd.
    Inventors: Seul Ki Jeon, Nam Woong Hur, Eung Hwan Kim, Jin Ho Gwon, Sang Hun Lee
  • Patent number: 10610104
    Abstract: The present disclosure relates to gastrointestinal (GI) tract detection methods, devices and systems.
    Type: Grant
    Filed: December 7, 2017
    Date of Patent: April 7, 2020
    Assignee: Progenity, Inc.
    Inventors: Brian Pak, John Mitchell McLean, Paul Timothy Smith, Mitchell Lawrence Jones, Christopher Loren Wahl
  • Patent number: 10602936
    Abstract: An implantable vital sign sensor including a housing including a first portion, the first portion defining a first open end, a second open end opposite the first end, and a lumen there through, the first portion being sized to be implanted substantially entirely within the blood vessel wall of the patient. A sensor module configured to measure a blood vessel blood pressure waveform is included, the sensor module having a proximal portion and a distal portion, the distal portion being insertable within the lumen and the proximal portion extending outward from the first open end.
    Type: Grant
    Filed: August 8, 2017
    Date of Patent: March 31, 2020
    Assignee: Thomas Jefferson University
    Inventor: Jeffrey I Joseph
  • Patent number: 10588552
    Abstract: A substance concentration analysis method includes calculating a difference for the particular time between a first measured amount of mid-infrared (MIR) radiation absorbed by or emitted from a body in a first wavelength and a second measured amount of MIR radiation absorbed by or emitted from the body in a second wavelength, calculating a quotient including a dividend based on the difference divided by a divisor based on a dT/dt value, and calculating the concentration of the substance in the body based on a correlation with the quotient.
    Type: Grant
    Filed: July 18, 2017
    Date of Patent: March 17, 2020
    Assignee: GlucoVista Inc.
    Inventors: Yonatan Gerlitz, Efraim Landa, Alexander Ostritsky
  • Patent number: 10575765
    Abstract: An implantable unit includes fluorescent sensor molecules, each of which includes a binding site for an analyte, a donor fluorophore, and an acceptor fluorophore; and a first light source. An external system includes an external reading unit, which includes a light sensor; and a processor, which is configured to (i) during a first time period: (a) drive the first light source to generate light having a first illumination peak wavelength appropriate for excitation of the donor fluorophore, and (b) receive, from the light sensor, a first measurement of the fluorescent light emitted from the acceptor fluorophore, (ii) during a second time period: (a) drive a second light source to generate light having a second illumination peak wavelength appropriate for direct excitation of the acceptor fluorophore, and (b) receive, from the light sensor, a second measurement of the fluorescent light emitted from the acceptor fluorophore, and (iii) calculate the concentration of the analyte based on the measurements.
    Type: Grant
    Filed: October 13, 2015
    Date of Patent: March 3, 2020
    Assignee: GLUSENSE LTD.
    Inventor: Boaz Brill
  • Patent number: 10575793
    Abstract: Systems, methods, and apparatuses that provide alerts based on analyte data and acceleration data. An analyte sensor may generate the analyte data. An accelerometer may generate the acceleration data. A transceiver may convert the analyte data into analyte concentration values. The transceiver may convert the acceleration data into activity information. The transceiver may generate an alert based on the analyte concentration values and activity information. The alert may be communicated to a user by a mobile medical application executed on the transceiver and/or a display device (e.g., smartphone) in communication with the transceiver. The mobile medical application may display (e.g., on a display of the display device) a plot or graph of the analyte concentration values and activity information with respect to time.
    Type: Grant
    Filed: April 12, 2017
    Date of Patent: March 3, 2020
    Assignee: Senseonics, Incorporated
    Inventors: Ravi Rastogi, Andrew DeHennis
  • Patent number: 10555670
    Abstract: A method and system of removing artifacts in electroencephalogram (EEG) signals is provided. Digital EEG data, based on a digitizing of analog EEG signals of a patient from a first electrode, is received. Digital sweat sensor data, based on a digitizing of analog sweat sensor signals of the patient that are contemporaneous with the analog EEG signals, is received. A transform is applied to the digital sweat sensor data based on a predetermined sweat stress profile of the patient. The digital EEG data is adaptively adjusted by subtracting the transformed sweat sensor data from the digital EEG data.
    Type: Grant
    Filed: July 10, 2017
    Date of Patent: February 11, 2020
    Assignee: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Payel Das, Ryan Hubbard
  • Patent number: 10542932
    Abstract: In one embodiment, measuring mitochondrial capacity includes performing arterial occlusions on a patient, measuring oxygenated hemoglobin/myoglobin and deoxygenated hemoglobin/myoglobin within the patient's body during the occlusions, calculating a blood volume correction factor that accounts for a change in blood volume that occurs during the arterial occlusions, and applying the correction factor to the measured oxygenated hemoglobin/myoglobin and deoxygenated hemoglobin/myoglobin measurements to obtain correct oxygenated hemoglobin/myoglobin and deoxygenated hemoglobin/myoglobin measurements.
    Type: Grant
    Filed: June 7, 2017
    Date of Patent: January 28, 2020
    Assignee: University of Georgia Research Foundation, Inc.
    Inventors: Kevin K. McCully, Terence E. Ryan
  • Patent number: 10537270
    Abstract: The subject matter discloses a device for measuring biological properties of an examined tissue, the device comprising at least one light source configured and operable to illuminate the examined tissue with light radiation of one or more wavelengths at a certain light illumination direction; and a light detector located at a same side of said examined tissue and configured and operable to receive light components of said one or more wavelengths reflected from the examined tissue in response to the illuminated light radiation at a certain light detection direction, and to generate measurement data indicative thereof; at least one of said light illumination direction and detection direction is positioned at an angle of at least 20 relative to an imaginary line perpendicular to the examined tissue or form an angle of at least 20 between the light illumination direction and detection direction.
    Type: Grant
    Filed: July 25, 2016
    Date of Patent: January 21, 2020
    Assignee: BIOBEAT TECHNOLOGIES LTD
    Inventors: Israel Sarussi, Arik Ben-Yishai, Johanan May
  • Patent number: 10524677
    Abstract: Systems are provided for detecting the flow of blood or other fluids in biological tissue by illuminating the biological tissue with a coherent light source and detecting time-varying patterns of constructive and destructive interference in light received from portions of the biological tissue by an imager. The movement of blood cells and other light-scattering elements in the biological tissue causes transient, short-duration changes in light emitted from portions of the biological tissue proximate to the moving blood cells or other scatterers. High-frequency sampling or other high-bandwidth processing of light intensities detected by an imager could be used to determine the flow of blood or other fluids at a plurality of points in the biological tissue, to detect and/or localize a tumor in the biological tissue, to determine the location, pattern, width, or other properties of vasculature in the biological tissue, or to provide information for some other application(s).
    Type: Grant
    Filed: November 9, 2017
    Date of Patent: January 7, 2020
    Assignee: Verily Life Sciences LLC
    Inventors: Andrew Homyk, Jason D. Thompson
  • Patent number: 10524676
    Abstract: The present application discloses an apparatus for determining a health parameter of a subject. The apparatus includes one or more biometric sensors configured to detect one or more biometric signals of the subject; a memory; and at least one processor. The memory stores computer-executable instructions for controlling the at least one processor to receive the one or more biometric signals from the one or more biometric sensors; classify physiological state of the subject as one of a plurality of physiological states comprising at least a first physiological state and a second physiological state based on the one or more biometric signals, the first physiological state being different from the second physiological state; and calculate the health parameter of the subject using one of a plurality of algorithms comprising at least a first algorithm corresponding to the first physiological state and a second algorithm corresponding to the second physiological state.
    Type: Grant
    Filed: January 25, 2017
    Date of Patent: January 7, 2020
    Assignee: BOE TECHNOLOGY GROUP CO., LTD.
    Inventor: Ruisi Chen
  • Patent number: 10524660
    Abstract: A system and method for detecting the amount or concentration of an analyte in a medium in living organism. The system may include an analyte sensor module and a transmitter module, which may be separate and distinct components. The analyte sensor module and transmitter module may be at different locations but connected by one or more transmission elements. The analyte sensor may include indicator elements configured to exhibit a detectable property based on the amount or concentration of the analyte in proximity to the indicator elements. The analyte sensor may include sensor elements configured to generate a data signal based on the detectable property exhibited by the indicator elements. The transmission elements may be configured to convey data signals generated by the sensor elements from the analyte sensor module to the transmitter module. The transmitter module may include an antenna.
    Type: Grant
    Filed: July 9, 2018
    Date of Patent: January 7, 2020
    Assignee: Senseonics, Incorporated
    Inventors: Andrew DeHennis, Todd Whitehurst